For the Inventor, By the Inventor

Enter assignee name

King of Prussia, PA, United States of America

Trevena, Inc.

USPTO Granted Patents = 25

% Expired Patents = 12.0

EPO Patents = 5

Trademarks = 4

Forward Citations = 90

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Dennis Shinji Yamashita (18 out of 34 patents)

Philip Michael Pitis (13 out of 56 patents)

Guodong Liu (13 out of 14 patents)

4. Xiao-Tao Chen (12 out of 22 patents)

5. Catherine C K Yuan (12 out of 14 patents)

6. Dimitar B Gotchev (7 out of 20 patents)

7. Aimee Crombie Speerschneider (6 out of 6 patents)

8. Michael John Hawkins (6 out of 7 patents)

9. Tamara Ann Miskowski Daubert (6 out of 6 patents)

10. Robert Borbo Kargbo (5 out of 5 patents)

11. Robert Jason Herr (5 out of 5 patents)

12. Donna Romero (5 out of 5 patents)

13. Patrick J Koestler (3 out of 3 patents)

14. Brian H Heasley (2 out of 14 patents)

15. Gregory J Pacofsky (2 out of 2 patents)

Core Competencies:

Opioid Receptor

S1P1 Modulators

Beta-Arrestin

Aza-Heterocyclic Compounds

Hyperalgesia Treatment

Crystalline Forms

Amorphous Forms

Ligands

Compounds

Methods

Compositions

Synthesis

25 patents: Sort by Forward Citations

1. 12686675 - Compounds and methods of preparing compounds S1P1 modulators (2026-07-21),

2. 12679825 - Crystalline and amorphous forms of a δ-opioid modulator (2026-07-14),

3. 11931350 - Opioid receptor ligands and methods of using and making same (2024-03-19),

4. 11912713 - 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2024-02-27),

5. 11912693 - Compounds for modulating S1P1 activity and methods of using the same (2024-02-27),

6. 11884655 - Compounds and methods of preparing compounds S1P1 modulators (2024-01-30),

7. 11702408 - 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2023-07-18),

8. 11465980 - 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2022-10-11),

9. 11225487 - 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same (2022-01-18),

10. 11077098 - Opioid receptor ligands and methods of using and making same (2021-08-03),

11. 10588898 - Opioid receptor ligands and methods of using and making same (2020-03-17),

12. 10588889 - Methods of treating hyperalgesia (2020-03-17),

13. 10246436 - 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2019-04-02),

14. 9849119 - Opioid receptor ligands and methods of using and making same (2017-12-26),

15. 9611293 - Synthesis of beta-arrestin effectors (2017-04-04),

Trevena, Inc. is a biopharmaceutical company based in King of Prussia, Pennsylvania, specializing in the development of innovative therapies for patients with central nervous system disorders. The company focuses on creating novel pain management solutions and treatments for various conditions, utilizing its proprietary drug discovery platform. Trevena is committed to advancing its research in the field of neurology and pain management, aiming to improve patient outcomes through targeted and effective therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

25 Patents

#6 in King of Prussia, PA

#491 in Pennsylvania

#13,350 in US

#25,681 in the World

King of Prussia, PA, United States of America

Trevena, Inc.

Forward Citations = 90

34 inventors:

Dennis Shinji Yamashita (18 out of 34 patents)

Philip Michael Pitis (13 out of 56 patents)

Guodong Liu (13 out of 14 patents)

4. Xiao-Tao Chen (12 out of 22 patents)

5. Catherine C K Yuan (12 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…